Switzerland Infection Control Market Size, Share, Opportunities, COVID-19 Impact, And Trends By Product (Disinfectants, Sterilization (Low-Temperature Sterilization, Heat Sterilization, Contract Sterilization)), By End User Industry (Healthcare, Food And Beverage, Chemical) - Forecasts From 2022 To 2027

  • Published : Aug 2022
  • Report Code : KSI061613370
  • Pages : 90

The Switzerland infection control market is projected to grow at a CAGR of 13.97% to reach US$655.372 million by 2027 from US$262.455 million in 2020.

In Switzerland, 45% of the population who are employed are exposed to some sort of risk, which is inclusive of but not limited to toxic products. In 2017, chronic hazardous drinking was observed among 5% of the population, and 16% got drunk at least once a month.

High health expenditure and new cases of infectious diseases

Furthermore, in 2018, there were 425 new diagnoses of HIV. Further, the ratio between health expenditure and the gross domestic product (GDP) was to the tune of 12.4% in 2017, which in turn makes Switzerland a part of those European countries with the highest ratio and, second after the USA, the country that was leading in health expenditure in relation to GDP in 2017.

Health expenditure by the government to drive the future growth

Moreover, in 2017, households financed 65% of health expenditures; mandatory health insurance premiums from households covered 30% of health expenditures. Further, the government’s contribution to health expenditure was 29%, with over 6 in every 10 francs of this public funding corresponding to payments from the cantons and communes to hospitals, nursing homes, and home care services. Additionally, the total health expenditure was 82,774 CHF million in 2017 [Source: Health Pocket Statistics 2019 Federal Statistics Office].

Thus, from the aforesaid, it is evident that there is a certain percent of the population that gets admitted to hospitals, and there are chances of getting admitted to hospitals due to the very nature of their work. They are unquestionably in danger of developing nosocomial infections, as defined by the World Health Organization (WHO), as a result of this. This necessitates much stricter and more severe infection prevention practices. Furthermore, given Switzerland's high ratio of health spending to GDP, all the aforementioned factors are anticipated to contribute to the market for infection control there expanding. 

Rising awareness of adherence to hygienic processes is driving the market:

The rising awareness of adherence to hygienic processes means the market for infection control in Switzerland is poised to grow at a healthy rate during the forecast period. Additionally, as of 2017 [Source: Federal Statistics Office], the average monthly disposable income per household was 6984 francs. Moreover, due to stringent regulatory compliance and the inclusion of technically enhanced instruments, there has been a growing need for advanced sterilizers that are tailor-made for these devices, which in the expanding use of low-temperature sterilizers with their diverse range of technologies, including ethylene oxide (EtO), vaporized hydrogen peroxide (VHP), hydrogen peroxide gas plasma, and ozone gas-based sterilization, is encouraging further investment in research and development. The booming tourism industry, which is also anticipated to restrain the upward trend in infection control sales in Switzerland, is the other factor in addition to those already mentioned. The mainstay of the economy necessitates the inclusion of hygienic processes in the food and beverage industry.

COVID-19 SCENARIO

The pandemic of COVID-19 had a huge impact on the Switzerland infection control market. The pandemic has caused havoc on healthcare systems around the world, with hospitals becoming overcrowded as the number of patients climbs. Temporary hospitals are being built to handle the influx of cases. The spread of COVID-19 has caused a boom in demand for cleaning and disinfection products because of the heightened awareness about cleanliness, health, and safety. However, it is anticipated that the infection control business will suffer severely in the post-COVID situation.

Key Developments

  • March 2022 - The market introduction of the Synbio cleaning line in Switzerland has been announced by HeiQ, a materials innovation business with headquarters in the Greater Zurich Area. Probiotics are used in this technology to effectively clean surfaces and textiles while safeguarding people, animals, and the environment.
  • April 2021 - Swiss researchers are releasing a self-cleaning mask. A mask that automatically disinfects itself at the touch of a button. The mask has been created by researchers from the Zurich University of Applied Sciences (ZHAW) and Swiss research and development firm Osmotex AG. According to data given by ZHAW, the electrochemical textile-based prototype of the mask has a greater than 95% antiviral impact.

Segmentation

  • By Product
    • Disinfectants
    • Sterilization
      • Low-Temperature Sterilization
      • Heat Sterilization
      • Contract Sterilization
  • By End User Industry
    • Healthcare
    • Food and Beverage
    • Chemical

1. Introduction
1.1.  Market Overview
1.2. COVID-19 Scenario
1.3. Market Definition
1.4. Market Segmentation

2.  Research Methodology
2.1.  Research Data
2.2.  Assumptions

3.  Executive Summary
3.1.  Research Highlights

4. Market Dynamics
4.1. Market Drivers
4.2. Market Restraints
4.3. Porter’s Five Forces Analysis
4.3.1. Bargaining Power of Suppliers
4.3.2. Bargaining Power of Buyers
4.3.3. Threat of New Entrants
4.3.4.  Threat of Substitutes
4.3.5. Competitive Rivalry in the Industry
4.4. Industry Value Chain Analysis

5. Switzerland Infection Control Market By Product
5.1.  Introduction
5.2. Disinfectant
5.3. Sterilization 
5.3.1.  Low-Temperature Sterilization
5.3.2.  Heat Sterilization
5.3.3. Contact Sterilization

6. Switzerland Infection Control Market By End-User Industry
6.1. Introduction
6.2. Healthcare
6.3. Food and Beverage
6.4. Chemical

7. Competitive Environment and Analysis
7.1. Major Players and Strategy Analysis
7.2.  Emerging Players and Market Lucrativeness
7.3.  Mergers, Acquisitions, Agreements, and Collaborations
7.4.  Vendor Competitiveness Matrix

8. Companies Profiles
8.1. Belimed 
8.2.  DGM Infection Control Systems 
8.3.  Steelco S.p.A.
8.4.  Tuttnauer

Belimed

DGM Infection Control Systems

Steelco S.p.A.

Tuttnauer